Volume 27, Number 2—February 2021
Research
Rapid Transmission of Severe Acute Respiratory Syndrome Coronavirus 2 in Detention Facility, Louisiana, USA, May–June, 2020
Megan Wallace1
, Allison E. James1, Rachel Silver, Mitsuki Koh, Farrell A. Tobolowsky, Sean Simonson, Jeremy A. W. Gold, Rena Fukunaga, Henry Njuguna, Keith Bordelon, Jonathan Wortham, Melissa Coughlin, Jennifer L. Harcourt, Azaibi Tamin, Brett Whitaker, Natalie J. Thornburg, Ying Tao, Krista Queen, Anna Uehara, Clinton R. Paden, Jing Zhang, Suxiang Tong, Danielle Haydel, Ha Tran, Kaylee Kim, Kiva A. Fisher, Mariel Marlow, Jacqueline E. Tate, Reena H. Doshi, Theresa Sokol, and Kathryn G. Curran
, Allison E. James1, Rachel Silver, Mitsuki Koh, Farrell A. Tobolowsky, Sean Simonson, Jeremy A. W. Gold, Rena Fukunaga, Henry Njuguna, Keith Bordelon, Jonathan Wortham, Melissa Coughlin, Jennifer L. Harcourt, Azaibi Tamin, Brett Whitaker, Natalie J. Thornburg, Ying Tao, Krista Queen, Anna Uehara, Clinton R. Paden, Jing Zhang, Suxiang Tong, Danielle Haydel, Ha Tran, Kaylee Kim, Kiva A. Fisher, Mariel Marlow, Jacqueline E. Tate, Reena H. Doshi, Theresa Sokol, and Kathryn G. Curran
Table 1
Characteristics of detained persons tested for SARS-CoV-2 in a correctional facility, Louisiana, USA, by dormitory, May–June 2020*
| Characteristic | Dormitory A, n = 20 | Dormitory B, n = 23 | Dormitory C, n = 11 | Dormitory D, n = 37 | Dormitory E, n = 7 | Dormitory F, n = 45 | Total, N = 143 |
|---|---|---|---|---|---|---|---|
| Median age, y (IQR) |
37 (29–47) |
31 (29–36) |
45 (35–52) |
31 (29–39) |
37 (29–47) |
32 (24–41) |
33 (28–42) |
| Sex | |||||||
| M | 20 (100) | 23 (100) | 11 (100) | 37 (100) | 0 | 45 (100) | 136 (95) |
| F |
0 |
0 |
0 |
0 |
7 (100) |
0 |
7 (5) |
| Race/ethnicity | |||||||
| White non-Hispanic | 10 (50) | 6 (26) | 7 (64) | 5 (14) | 2 (29) | 5 (11) | 36 (25) |
| Black non-Hispanic | 10 (50) | 16 (70) | 4 (36) | 30 (81) | 5 (71) | 37 (82) | 102 (71) |
| Asian non-Hispanic | 0 | 0 | 0 | 1 (3) | 0 | 0 | 1 (1) |
| Hispanic/Latino |
0 |
0 |
0 |
1 (3) |
0 |
3 (8) |
4 (3) |
| Underlying health condition | |||||||
| Any | 8 (40) | 7 (30) | 7 (64) | 14 (38) | 3 (43) | 10 (22) | 49 (34) |
| Respiratory disease | 3 (15) | 3 (13) | 3 (27) | 5 (14) | 1 (14) | 3 (7) | 18 (13) |
| Asthma | 1 (5) | 1 (4) | 3 (27) | 4 (11) | 0 | 3 (7) | 12 (8) |
| Diabetes | 1 (5) | 0 | 3 (27) | 0 | 2 (29) | 1 (2) | 7 (5) |
| Hypertension | 3 (15) | 3 (13) | 5 (45) | 7 (19) | 2 (29) | 7 (15) | 27 (19) |
| Other CVD | 0 | 1 (4) | 0 | 2 (5) | 0 | 1 (2) | 4 (3) |
| Other† |
4 (15) |
2 (8) |
1 (9) |
2 (5) |
0 |
1 (2) |
10 (7) |
| Obesity, BMI >30 kg/m2 | 6 (30) | 7 (30) | 1 (9) | 7 (19) | 2 (29) | 6 (13) | 29 (20) |
| Any past tobacco use |
12 (60) |
5 (22) |
8 (73) |
14 (38) |
4 (57) |
17 (38) |
60 (42) |
| Dormitory | |||||||
| Capacity at start of study | 20/30 (67) | 23/30 (77) | 11/22 (50) | 37/50 (74) | 7/22 (32) | 45/50 (90) | NA |
| Toilets/sinks | 3 | 3 | 4 | 3 | 4 | 3 | NA |
| Showers/person | 3 | 3 | 2 | 3 | 2 | 2 | NA |
*Values are no. (%) or no. unless indicated otherwise. BMI, body mass index; CVD, cardiovascular disease; IQR, interquartile range; NA, not applicable; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2. †Includes liver disease, immunosuppressive disorder, and neurologic disease.
1These authors contributed equally to this article.
Page created: November 02, 2020
Page updated: January 23, 2021
Page reviewed: January 23, 2021
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.